Get the Weekly Intelligence Brief — top committee picks every Sunday.
ESTA · NASDAQ · STOCK

Establishment Labs Holdings Inc.

Healthcare Updated August 11, 2026
$74.23
52W $33.35 – $97.59
55/100
$2.19B
-56.8
1.09
AI Committee Verdict
Watch
55/100
Conviction: Contested · 50% agreement · 6 analysts
Contested

Is ESTA Bullish or Bearish?

Mixed. Innellis AI committee rates Establishment Labs Holdings Inc. (ESTA) Watch with a composite score of 55/100 , based on 6 analysts with 50% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +5.48 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -14.52 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 34.9% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 89.9x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Revenue growing 34.9% YoY -- genuine top-line momentum — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 89.9x prices in significant intangible value — Value
  • ROE of only -225.9% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 11.04 adds balance-sheet risk to the value case — Value
  • RSI at 15 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading below the lower Bollinger Band -- stretched to the downside — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 85%
of 192 Healthcare peers
Value Analyst bearish
32 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 89.9x prices in significant intangible value
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 34.9% YoY -- genuine top-line momentum
Technical Analyst bearish
38 / 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 15 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 11.04) amplifies downside in a stress scenario
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
14.9
Oversold
MACD Histogram
-2.595
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$63.41
Resistance
$78.00
Bollinger %B
-0.06
Below Lower Band
Price vs Moving Averages
EMA 9
$82.81 Below
EMA 21
$86.51 Below
EMA 50
$84.65 Below
EMA 200
$70.93 Above

Fundamental Analysis

Valuation
67
Profitability
25
Financial Health
50
Cash Flow
15
Valuation
P/E Ratio -56.8×
P/B Ratio 103.55×
PEG Ratio -0.63
Dividend Yield 0.00%
52W High $97.59
52W Low $33.35
Quality & Growth
ROE -21686.0%
ROA -1429.7%
Gross Margin 7048.9%
Operating Margin -763.0%
Revenue Growth YoY
Debt / Equity 12.20
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -56.8 (inexpensive relative to a 15-40x range); Price-to-book of 103.6x; PEG ratio of -0.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -216.9%; Return on assets of -14.3%; Net margin of -15.8%; Gross margin of 70.5%; Current ratio of 3.84 (healthy short-term liquidity); Debt-to-equity of 12.20; Free cash flow per share is negative (-1.40); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full ESTA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore ESTA Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime